MedPage Today on MSN
Prior Biologic Use Tied to JAK Inhibitor Benefit in Ulcerative Colitis
In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...
A national audit of total abdominal colectomy for ulcerative colitis finds low 30 day mortality and a rise in laparoscopic procedures, a new Irish study finds.
A new study published in the journal of Inflammatory Bowel Disease shows low mortality and tolerable morbidity after total ...
As of Friday, January 09, Mesoblast Limited’s MESO share price has surged by 7.70%, which has investors questioning if this is right time to sell.
AbbVie continues to project low single-digit growth through 2030 as it expands its immunology franchise and makes a major ...
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") an innovative biotechnology company focused on developing transformative treatments for chronic inflammatory conditions and debilitating retinal ...
MRM Health receives US FDA IND clearance to initiate phase 2b trial of MH002 in mild-to-moderate ulcerative colitis: Ghent, Belgium Saturday, January 10, 2026, 16:00 Hrs [IST] MRM ...
The Body Optimist on MSN
Chronic inflammation: the invisible disease that will gain ground in 2026?
When an injury occurs or a microbe enters the body, inflammation kicks in to repair and protect. But what happens when this ...
A Europe-wide study led by the University Medical Center Göttingen (UMG) shows that the microbial composition of the gut, ...
A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...
The current study analyzed data from 10 Korean hospital databases and included a total of 5644 patients with AP. Patients with high triglycerides had significantly higher levels of C-reactive protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results